Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT04888338

Outcomes After Chimeric Antigen Receptor Therapy and Radiation Therapy for Hematologic Malignancies

Sponsor: M.D. Anderson Cancer Center

View on ClinicalTrials.gov

Summary

This study collects information on outcomes after chimeric antigen receptor therapy and radiation therapy for hematologic malignancies. Collecting information from patients before, during, and after receiving chimeric antigen receptor therapy or radiation therapy may help doctors to optimize patient selection, dose, timing, and sequencing of these treatments.

Official title: Outcomes After Chimeric Antigen Receptor Therapy (CAR-T) and Radiation Therapy (RT) for Hematologic Malignancies

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

OBSERVATIONAL

Enrollment

100

Start Date

2021-04-10

Completion Date

2026-11-14

Last Updated

2025-10-27

Healthy Volunteers

No

Interventions

OTHER

Data Capture

Treatment related data is collected

OTHER

Electronic Medical Record

Medical records are reviewed

Locations (1)

M D Anderson Cancer Center

Houston, Texas, United States